Feedback / Questions
DIAG-723 - Diagonal Therapeutics
https://www.manilatimes.net/2025/06/18/tmt-newswire/globenewswire/diagonals-first-in-class-clustering-antibody-diag723-receives-orphan-drug-designation-odd-from-us-fda-and-an-odd-positive-opinion-from-ema-for-treatment-of-hereditary-hemorrhagic-telangiectasia-hht/2135571
 
Jun 18, 2025
 
SHARE THIS
  • Print
  • Email
  • More sharing
    Reddit
    StumbleUpon
    Delicious